Efficacy and safety of outpatient management of moderate to severe ovarian hyperstimulation syndrome
Document Type
Original Article
Abstract
Background: One potentially dangerous side effect of assisted reproductive therapy is ovarian hyperstimulation syndrome. Hospitalization has long been a standard part of care for women with moderate to severe ovarian hyperstimulation syndrome, providing them with supportive care and careful observation.
Aim and Objectives: To assess the safety and effectiveness of managing moderate to severe ovarian hyperstimulation syndrome as an outpatient.
Patients and Methods: 140 women who met the inclusion and exclusion criteria for our observational cohort research received in vitro fertilization and had moderate to severe ovarian hyperstimulation syndrome. Intravenous hydration, paracentesis of the ascetic fluid, and anti-thrombo-embolic measures were the main lines of treatment.
Results: Merely 5. instances (3.6%) of the patients included were admitted to the hospital, while 135 cases (96.5%) were effectively handled as outpatients without needing a follow-up hospital stay.
Conclusion: This study suggests that When patients are properly chosen, outpatient therapy of moderate to severe ovarian hyperstimulation syndrome is a safe approach with no documented increase in morbidity or death.
Keywords
Outpatient; Ovarian hyperstimulation; Paracentesis; Hospitalization
Subject Area
Obstetrics and Gynecology
How to Cite This Article
Melad, Abdallah Mohammed Mohammed; Gebreel, Mohammed Mohammed; and Ibrahim, Adel El-Sayed
(2024)
"Efficacy and safety of outpatient management of moderate to severe ovarian hyperstimulation syndrome,"
Al-Azhar International Medical Journal: Vol. 5:
Iss.
4, Article 46.
DOI: https://doi.org/10.58675/2682-339X.2390
